AngioDynamics, Inc. (ANGO) Shares Bought by The Manufacturers Life Insurance Company
The Manufacturers Life Insurance Company grew its position in AngioDynamics, Inc. (NASDAQ:ANGO) by 32.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 29,321 shares of the medical instruments supplier’s stock after acquiring an additional 7,130 shares during the period. The Manufacturers Life Insurance Company owned 0.08% of AngioDynamics worth $475,000 at the end of the most recent reporting period.
Several other large investors have also recently bought and sold shares of ANGO. Janus Henderson Group PLC bought a new position in AngioDynamics in the 2nd quarter worth approximately $15,619,000. Wells Fargo & Company MN raised its position in AngioDynamics by 86.3% in the 2nd quarter. Wells Fargo & Company MN now owns 1,015,594 shares of the medical instruments supplier’s stock worth $16,463,000 after purchasing an additional 470,522 shares during the last quarter. Marshall Wace North America L.P. bought a new position in AngioDynamics in the 2nd quarter worth approximately $6,727,000. Vanguard Group Inc. raised its position in AngioDynamics by 14.4% in the 2nd quarter. Vanguard Group Inc. now owns 1,938,115 shares of the medical instruments supplier’s stock worth $31,416,000 after purchasing an additional 243,825 shares during the last quarter. Finally, Great Lakes Advisors LLC bought a new position in AngioDynamics in the 2nd quarter worth approximately $3,509,000. Institutional investors own 96.21% of the company’s stock.
ANGO has been the subject of several research analyst reports. Zacks Investment Research upgraded shares of AngioDynamics from a “hold” rating to a “buy” rating and set a $19.00 price objective for the company in a research report on Tuesday, October 3rd. Canaccord Genuity restated a “hold” rating and issued a $17.00 price objective on shares of AngioDynamics in a research report on Sunday, October 8th. KeyCorp restated a “hold” rating on shares of AngioDynamics in a research report on Friday, September 29th. Finally, BidaskClub upgraded shares of AngioDynamics from a “sell” rating to a “hold” rating in a research report on Saturday, August 19th. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $18.60.
AngioDynamics, Inc. (NASDAQ:ANGO) opened at $17.35 on Friday. The company has a quick ratio of 1.48, a current ratio of 2.34 and a debt-to-equity ratio of 0.17. AngioDynamics, Inc. has a 1 year low of $14.80 and a 1 year high of $18.85. The firm has a market cap of $637.02, a P/E ratio of 25.14, a P/E/G ratio of 1.78 and a beta of 1.05.
AngioDynamics (NASDAQ:ANGO) last posted its quarterly earnings data on Thursday, September 28th. The medical instruments supplier reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.04). The company had revenue of $85.40 million during the quarter, compared to the consensus estimate of $86.12 million. AngioDynamics had a return on equity of 4.83% and a net margin of 1.64%. The business’s revenue for the quarter was down 3.1% on a year-over-year basis. During the same quarter last year, the firm earned $0.17 EPS. analysts expect that AngioDynamics, Inc. will post 0.65 earnings per share for the current fiscal year.
AngioDynamics Company Profile
AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.
Receive News & Ratings for AngioDynamics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.